Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism
Condition(s):ThyrotoxicosisLast Updated:February 20, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):ThyrotoxicosisLast Updated:February 20, 2024Not yet recruiting
Condition(s):ThyrotoxicosisLast Updated:July 24, 2020Completed
Condition(s):Paediatric ThyrotoxicosisLast Updated:September 21, 2016Completed
Condition(s):Amiodarone-Induced ThyrotoxicosisLast Updated:October 11, 2021Terminated
Condition(s):Thyrotoxicosis; Graves Disease; ThyroiditisLast Updated:April 18, 2018Completed
Condition(s):THYROTOXICOSISLast Updated:January 7, 2020Recruiting
Condition(s):ThyrotoxicosisLast Updated:October 4, 2016Completed
Condition(s):Hyperthyroidism/ThyrotoxicosisLast Updated:March 12, 2024Active, not recruiting
Condition(s):Hyperthyroidism/ThyrotoxicosisLast Updated:August 23, 2022Completed
Condition(s):Thyrotoxicosis; Peak Systolic Velocity of Superior Thyroid Artery; Thyroiditis; Graves DiseaseLast Updated:May 5, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.